We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Lpath Temporarily Suspends Dosing of iSONEP Due to cGMP Compliance Issues

News   Jan 27, 2012

 
Lpath Temporarily Suspends Dosing of iSONEP Due to cGMP Compliance Issues
 
 
 

RELATED ARTICLES

Cracking a One-Two Punch Against Melanoma

News

Updated, safer versions of diphtheria fusion toxin DAB-IL-2 show promise in reducing tumor growth.

READ MORE

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

Sparing Sensitive Organs from Radiation Damage to Reduce Side Effects

News

A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumors to reduce side-effects, a new study shows.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE